Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000355

Type of data
NGS (Target Capture): AML cancer panel
NGS (Target Capture): 41 genes
Access criteria
Controlled-access (Type I)
Total data volume
25.3 GB
File formats
  • FASTQ
Research
hum0116
Date published
2020-11-24
Date modified
2021-03-29
DDBJ Search
JGAD000355 (opens in a new tab)
JGA Study
JGAS000122 (opens in a new tab)

Analysis method

Targeted DNA sequencing

Materials and participants
AML (ICD10: C920): 106 cases
1) peripheral blood: 45 samples
2) bone marrow aspirate: 19 samples
3) human leukemia cells from spleen of humanized mice with leukemia derived from immune deficiency mice which were infused with peripheral blood, bone marrow aspirate or samples from patients with AML: 6 samples
4) human leukemia cells from bone marrow aspirate of humanized mice with leukemia derived from immune deficiency mice which were infused with peripheral blood, bone marrow aspirate or samples from patients with AML: 36 samples
  • Health status
    Affected
  • Subject count
    106 (Individual)
Disease
AML (C920)
Sample description
DNAs extracted from peripheral blood and bone marrow aspirate
DNAs extracted from human leukemia cells from spleen and bone marrow aspirate of humanized mice with leukemia derived from immune deficiency mice which were infused with peripheral blood, bone marrow aspirate or samples from patients with AML
  • Tissue
    Bone marrow, Peripheral blood, Spleen
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
Targeted DNA sequencing
Target
Coding region of 41 genes (NRAS, KRAS, FLT3, TP53, NPM1, KIT, IDH1, IDH2, SF3B1, U2AF1, TET2, DNMT3A, ASXL1, ASXL2, BCOR, RUNX1, KMT2A(MLL), WT1(WT-1), GATA2, STAG2, RAD21, SMC1A, SMC3, MPL, NF1, PTPN11, CSF3R, CBL, CEBPA, SRSF2, DHX15, ZRSR2, EZH2, SETBP1, KDM6A, ETV6, CUX1, PHF6, MGA, ZBTB7A, PPM1D)
Reagent kit
Multiplex PCR + 2nd PCR
Fragmentation
N/A
Platform
Illumina HiSeq 2500
Read type
Paired-end
Read length
151 bp
Data use policy
NBDC data sharing policy (JGAP000001)